# Tamsulosin Monotherapy Versus Combination Therapy With Tadalafil (2.5 mg vs 5 mg) in Managing Male LUTS Secondary to BPH

> **NCT07722884** · NA · RECRUITING · sponsor: **Ain Shams University** · enrollment: 90 (estimated)

## Conditions studied

- Safety
- Efficacy
- Tamsulosin
- Monotherapy
- Tadalafil
- Lower Urinary Tract Symptoms
- Benign Prostatic Hyperplasia

## Interventions

- **DRUG:** Tamsulosin 0.4 mg + Tadalafil 2.5 mg
- **DRUG:** Tamsulosin 0.4 mg + Tadalafil 5 mg
- **DRUG:** Tamsulosin 0.4 mg

## Key facts

- **NCT ID:** NCT07722884
- **Lead sponsor:** Ain Shams University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-07-01
- **Primary completion:** 2027-01-01
- **Final completion:** 2027-01-01
- **Target enrollment:** 90 (ESTIMATED)
- **Last updated:** 2026-07-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07722884

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07722884, "Tamsulosin Monotherapy Versus Combination Therapy With Tadalafil (2.5 mg vs 5 mg) in Managing Male LUTS Secondary to BPH". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07722884. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*